Patients were randomized (sequential series of 4 per block, sealed envelopes, computer generated randomization code) to receive either an oral liquid formulation of L-Carnitine (4 g/d, obtained from Lonza, Basel, CH) or identically formulated placebo with follow up visits at 6 and 12 weeks after entry
This comparison is distinct from IGF-1 LR3 vs MGF (ID 77399), IGF-1 LR3 vs CJC-1295 (ID 77457), and Follistatin vs ACE-031 (ID 77433) this post examines the direct mechanistic head-to-head between IGF-1R-driven anabolic cascade biology and myostatin-ActRIIB inhibition biology as parallel skeletal muscle hypertrophy research strategies
SeekPeptides provides evidence-based guides, vendor reviews, and comparison tools that help researchers evaluate their options objectively, without the influence of affiliate commissions or vendor partnerships
D., Warrier, M., Brown, J